Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > 800,000 shares, whatd up shortie 7 TD Sec

<< Previous

Bullboard Posts

Next >>

Post by Dude51on May 26, 2021 9:37am

181 Views

Post# 33266788

800,000 shares, whatd up shortie 7 TD Sec

Time ET	Ex	Price	Change	Volume	Buyer	Seller	Markers
09:31:06	V	0.035		200	88 Credential	68 Leede
09:31:06	V	0.035		900	7 TD Sec	68 Leede
09:31:06	V	0.035		17,000	88 Credential	33 Canaccord	K
09:31:06	V	0.035		18,000	79 CIBC	33 Canaccord	K
09:31:03	V	0.035		7,000	79 CIBC	7 TD Sec	K
09:31:03	V	0.035		793,000	9 BMO Nesbitt	7 TD Sec	K
09:30:05	V	0.035		100,000	9 BMO Nesbitt	89 Raymond James	K
09:30:00	V	0.035		28,000	9 BMO Nesbitt	1 Anonymous	KL
09:30:00	V	0.035		40,000	9 BMO Nesbitt	80 National Bank	KL
09:30:00	V	0.035		3,000	9 BMO Nesbitt	68 Leede	KL